Severe Pediatric Asthma Therapy: Mepolizumab
There is a growing need for advanced treatment in children with persistent and severe asthma symptoms. As a matter of fact, between 2 and 5% of asthmatic children experience repeated hospitalizations and poor quality of life despite optimized treatment with inhaled glucocorticoid plus a second contr...
Сохранить в:
Главные авторы: | Nicola Ullmann (Автор), Francesca Peri (Автор), Olivia Florio (Автор), Federica Porcaro (Автор), Elisa Profeti (Автор), Alessandro Onofri (Автор), Renato Cutrera (Автор) |
---|---|
Формат: | |
Опубликовано: |
Frontiers Media S.A.,
2022-07-01T00:00:00Z.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
-
Difficult and Severe Asthma in Children
по: Federica Porcaro, и др.
Опубликовано: (2020) -
Severe Asthma and Allergy: A Pediatric Perspective
по: Stefania Arasi, и др.
Опубликовано: (2019) -
Asthma: Differential Diagnosis and Comorbidities
по: Nicola Ullmann, и др.
Опубликовано: (2018) -
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
по: Mattia Giovannini, и др.
Опубликовано: (2019) -
Mepolizumab in Severe Pediatric Asthma: Certainties and Doubts through a Single-Center Experience and Review of the Literature
по: Marco Maglione, и др.
Опубликовано: (2024)